Lexington, MA, United States of America

Kristin Narayan

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2022-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kristin Narayan: Innovator in Polypeptide Research

Introduction

Kristin Narayan is a prominent inventor based in Lexington, MA (US). She has made significant contributions to the field of biotechnology, particularly in the development of engineered polypeptides and their applications in medicine. With a total of 2 patents, her work is paving the way for advancements in treatment and prevention of various disorders.

Latest Patents

Kristin's latest patents include innovative research on engineered polypeptides and their uses. One of her notable patents focuses on polypeptides, such as antibody molecules and fusion proteins, that comprise an Fc region. These polypeptides can be utilized to treat, prevent, and diagnose various disorders. Another significant patent relates to compositions and methods for treating and preventing influenza. This disclosure involves binding agents, such as antibodies and antigen-binding fragments, that specifically bind to the hemagglutinin protein of influenza viruses, along with methods for their application.

Career Highlights

Kristin Narayan is currently associated with Visterra, Inc., where she continues to push the boundaries of scientific research. Her work has garnered attention for its potential impact on public health and disease management.

Collaborations

Some of her notable coworkers include Susan Sloan and Jill Yarbrough, who contribute to the collaborative environment at Visterra, Inc.

Conclusion

Kristin Narayan's innovative work in polypeptide research exemplifies the vital role of inventors in advancing medical science. Her contributions are essential in the ongoing fight against diseases, particularly influenza, showcasing the importance of research and collaboration in the field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…